ConductScience.org, home

Paper9875583

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.

Mwinga A and 11 others. AIDS, 1998. Cited by 199 papers, by iCite.

Cite this record

ConductScience Library. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. Papers, record 9875583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9875583

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
PubMed
Journal
AIDS
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
199
iCite
Relative citation ratio, by iCite
6.26
iCite
Revised in PubMed
2019-07-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mwinga AA
2Hosp MM
3Godfrey-Faussett PP
4Quigley MM
5Mwaba PP
6Mugala BNB N
7Nyirenda OO
8Luo NN
9Pobee JJ
10Elliott AMA M
11McAdam KPK P
12Porter JDJ D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related Opportunistic InfectionsMajor topic
Antibiotic ProphylaxisMajor topic
Antitubercular AgentsMajor topic
IsoniazidMajor topic
PyrazinamideMajor topic
RifampinMajor topic
Tuberculosis, PulmonaryMajor topic
Adult
Antibiotics, Antitubercular
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Incidence
Male
Patient Compliance
Treatment Outcome
Tuberculin Test
Zambia

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 199 citations.

PMIDTitleJournalYearIn PapersSource
39374926Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea.Tuberc Respir Dis (Seoul)2025https://conductscience.org/library/papers/39374926PubMed
37444057Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.Int J Environ Res Public Health2023https://conductscience.org/library/papers/37444057PubMed
35769848Mycobacterial infections in solid organ transplant recipients.Korean J Transplant2021https://conductscience.org/library/papers/35769848PubMed
34903214Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.BMC Med2021https://conductscience.org/library/papers/34903214PubMed
34520459Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.PLoS Med2021https://conductscience.org/library/papers/34520459PubMed
33579394Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania.Trop Med Health2020https://conductscience.org/library/papers/33579394PubMed
32918195Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.Curr HIV/AIDS Rep2020https://conductscience.org/library/papers/32918195PubMed
32411454Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study.AIDS Res Treat2020https://conductscience.org/library/papers/32411454PubMed
31364692Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.Am J Epidemiol2019https://conductscience.org/library/papers/31364692PubMed
30885144Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015.BMC Infect Dis2019https://conductscience.org/library/papers/30885144PubMed
28724374Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.BMC Public Health2017https://conductscience.org/library/papers/28724374PubMed
28409555Treatment of Latent Tuberculosis Infection.Microbiol Spectr2017https://conductscience.org/library/papers/28409555PubMed
26352882High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.AIDS2015https://conductscience.org/library/papers/26352882PubMed
26258564Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.J Acquir Immune Defic Syndr2015https://conductscience.org/library/papers/26258564PubMed
25768869Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.J Acquir Immune Defic Syndr2015https://conductscience.org/library/papers/25768869PubMed
25365974Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.Clin Infect Dis2015https://conductscience.org/library/papers/25365974PubMed
23535699Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study.BMJ Open2013https://conductscience.org/library/papers/23535699PubMed
23382740HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon.Afr Health Sci2012https://conductscience.org/library/papers/23382740PubMed
23251327Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.PLoS One2012https://conductscience.org/library/papers/23251327PubMed
22581360Treatment of latent tuberculosis infection in HIV: shorter or longer?Curr HIV/AIDS Rep2012https://conductscience.org/library/papers/22581360PubMed

See all 53 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9875583

GET https://conductscience.org/api/papers/v1/9875583/cited_by?page=2